Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guihuang Decoction
- Development stage
- Preclinical
- Lead developer
- Xiyuan Hospital
- Administration
- Oral
01
Overview
Guihuang Decoction is a traditional Chinese medicine compound or formula that is being investigated for the treatment of chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS). Clinical studies have indicated its efficacy and safety in treating type III prostatitis with damp-heat stasis syndrome. Its therapeutic effects are believed to stem from its ability to reduce inflammation, alleviate oxidative stress, and suppress apoptosis in macrophages. The drug has been shown to decrease immune cell infiltration in the prostate and downregulate the expression of various proinflammatory cytokines.
- Brand names
- Guihuang
- Other names
- Guihuang FormulaGHFGuihuang prescription
Beyond the preview
Go deeper on Guihuang Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guihuang Decoction.